Form 4: Lemaitre Vascular Inc. Executive Receives Stock Options and Restricted Stock Units

Sentiment:

Equity Grant Filing


Lemaitre Vascular Inc. grants stock options and restricted stock units to executive Martha Shadan.

Summary

  • Lemaitre Vascular Inc. granted Martha Shadan stock options to purchase 420 shares of common stock at $101.12 per share.
  • Additionally, Martha Shadan received 2,594 restricted stock units.
  • The stock options vest over a three-year period, with 33 1/3% vesting on the first anniversary of the grant date and the remainder vesting in equal annual installments over the next two years.
  • The restricted stock units also vest over a three-year period, with 33 1/3% vesting on the first anniversary of the grant date and the remainder vesting in equal annual installments over the next two years.

Sentiment

Score: 7

Explanation: The document reflects a standard corporate practice of incentivizing executives with equity, which is generally viewed positively. There are no indications of negative sentiment.

Positives

  • The grant of stock options and restricted stock units aligns executive compensation with company performance and shareholder value.
  • The vesting schedule encourages long-term commitment from the executive.

Risks

  • The value of the stock options is dependent on the future stock price of Lemaitre Vascular Inc.

Industry Context

The granting of stock options and restricted stock units is a common practice in the corporate world to incentivize and retain key executives.

Comparison to Industry Standards

  • Stock option and restricted stock unit grants are standard practice for executive compensation across various industries, including medical device companies.
  • Vesting schedules of three years are also common, aligning executive interests with long-term company performance.
  • Companies like Medtronic and Boston Scientific also use similar equity-based compensation plans for their executives.

Stakeholder Impact

  • Shareholders may view this as a positive step in aligning executive interests with company performance.
  • Employees may see this as a sign of the company's commitment to its leadership.

Key Dates

DateDescription
2024-12-06Grant date for stock options and restricted stock units.
2024-12-10Date of signature on the filing.
2029-12-06End of the vesting period for the stock options and restricted stock units.

Keywords

stock options, restricted stock units, executive compensation, vesting, Lemaitre Vascular Inc, LMAT

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.